EP Patent

EP3821889A1 — Methods for using low-dose colchicine after myocarial infarction

Assigned to Institut de Cardiologie de Montreal · Expires 2021-05-19 · 5y expired

What this patent protects

The invention relates to colchicine for use in a method of treating a patient after having a myocardial infarction (MI), the method including initiating the administration of colchicine at a daily low dose to the patient within about 30 days of the MI.

USPTO Abstract

The invention relates to colchicine for use in a method of treating a patient after having a myocardial infarction (MI), the method including initiating the administration of colchicine at a daily low dose to the patient within about 30 days of the MI.

Drugs covered by this patent

Patent Metadata

Patent number
EP3821889A1
Jurisdiction
EP
Classification
—
Expires
2021-05-19
Drug substance claim
No
Drug product claim
No
Assignee
Institut de Cardiologie de Montreal
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.